547
Views
4
CrossRef citations to date
0
Altmetric
Immunology

Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting

, , , &
Pages 386-396 | Accepted 20 Nov 2015, Published online: 29 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Duncan Short, Xueqi Wang, Shivali Suri, Thomas K Hsu, Bryn Jones, Rob J Fredericksen, Heidi M Crane, Alexandra Musten, Jean Bacon, Yongwei Wang, Kevin A Gough, Moti Ramgopal, Jeff Berry & William B Lober. (2022) Risk Factors for Suboptimal Adherence Identified by Patient-Reported Outcomes Assessments in Routine HIV Care at 2 North American Clinics. Patient Preference and Adherence 16, pages 2461-2472.
Read now
Adrienne M. Gilligan, Jessica Franchino-Elder, Xue Song, Cheng Wang, Caroline Henriques, Amy Sainski-Nguyen, Kathleen Wilson, David M. Smith & Stephen Sander. (2018) Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants. Current Medical Research and Opinion 34:2, pages 285-295.
Read now

Articles from other publishers (2)

Sri Yona, Chiyar Edison, Astuti Yuni Nursasi & Rita Ismail. (2023) Self-awareness as the key to successful adherence to antiretroviral therapy among people living with HIV in Indonesia: A grounded theory study. Belitung Nursing Journal 9:2, pages 176-183.
Crossref
Adrienne M. Gilligan, Pranav Gandhi, Xue Song, Cheng Wang, Caroline Henriques, Stephen Sander & David M. Smith. (2017) All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin. American Journal of Cardiovascular Drugs 17:6, pages 481-492.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.